Piritrexim
Piritrexim (BW 301U) is an orally available fat-soluble dihydrofolate reductase inhibitor with pulmonary toxicity used in the study of uroepithelial carcinoma and metastatic breast cancer.
Product Specifications
CAS Number
72732-56-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
325.37
Molecular Formula
C17H19N5O2
Notes
Research use only, not for human use.
Receptor
DHFR
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1242077-01 0.05 mg (E-Coli)
Recombinant Conus achatinus Omega-conotoxin-like Ac6.5
Ask
View Details 
MBS1242077-02 0.2 mg (E-Coli)
Recombinant Conus achatinus Omega-conotoxin-like Ac6.5
Ask
View Details MBS1242077-03 0.05 mg (Yeast)
Recombinant Conus achatinus Omega-conotoxin-like Ac6.5
Ask
View Details 
MBS1242077-04 0.5 mg (E-Coli)
Recombinant Conus achatinus Omega-conotoxin-like Ac6.5
Ask
View Details MBS1242077-05 0.05 mg (Baculovirus)
Recombinant Conus achatinus Omega-conotoxin-like Ac6.5
Ask
View Details MBS1242077-06 0.2 mg (Yeast)
Recombinant Conus achatinus Omega-conotoxin-like Ac6.5
Ask
View Details